National Cancer Centre Singapore

Singapore, Central Singapore 169610

1 studies enrolling now · 4 studies all time

What they study most

Any Solid Tumor, Breast Cancer, Colon Cancer, Medullary Thyroid Cancer, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Other Solid Tumors With Evidence of Activating RET Alteration, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Papillary Thyroid Cancer, Untreated, Unresectable, or Metastatic Colorectal Cancer

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now
• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
• Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation — APPROVED_FOR_MARKETING